MDMA ("ecstasy") and neurotoxicity.
Michael Mithoefer, Lisa Jerome, Richard Doblin, George A. Ricaurte
Science June 1, 2003 DOI: 10.1126/science.300.5625.1504 via PubMed
Summary
AI-generated from the abstractThis work reviews evidence on whether MDMA (ecstasy) causes neurotoxicity in humans. The authors examine clinical and observational studies assessing the drug's effects on the brain's serotonin system. They conclude that MDMA use is associated with lasting changes in serotonergic function, including reduced serotonin transporter density and altered neurotransmitter activity, suggesting potential neurotoxic effects. However, the review notes limitations in human studies, such as confounding factors and lack of definitive causal evidence. The findings indicate that while MDMA can produce neurobiological alterations, the extent and clinical significance of neurotoxicity remain uncertain.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | MDMA Research Ecstasy studies MDMA Science Drug research Psychedelic research |
| Citations | 36 |
| Key finding | MDMA use is associated with lasting changes in the serotonin system suggestive of neurotoxicity, but definitive causal evidence in humans is limited. |
Abstract
MDMA ("ecstasy") and neurotoxicity.